1st Quarter - Report — UCB, INC. for UCB, INC. (2023)

Firm

UCB, INC.

Client

UCB, INC.

Income

—

Expenses

$440,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 830 - HELP Copays Act H.R. 2163 - Safe Step Act S. 464 - Safe Step Act Inflation Reduction Act Orphan Drug Tax Credit

Lobbyist	Covered position, as disclosed
JED PERRY	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 464 (118th), H.R. 2163 (118th), H.R. 830 (118th)

Taxation/Internal Revenue Code TAX

Inflation Reduction Act Orphan Drug Tax Credit Research and Development Tax Credit Amortization

Lobbyist	Covered position, as disclosed
JED PERRY	—

Contacted: HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Inflation Reduction Act

Lobbyist	Covered position, as disclosed
JED PERRY	—

Contacted: HOUSE OF REPRESENTATIVES

Insurance INS

H.R. 830 - HELP Copays Act

Lobbyist	Covered position, as disclosed
JED PERRY	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 830 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.